Global Organoid Biobank Supply, Demand and Key Producers, 2023-2029
The global Organoid Biobank market size is expected to reach $ 389.7 million by 2029, rising at a market growth of 17.7% CAGR during the forecast period (2023-2029).
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
This report studies the global Organoid Biobank demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Organoid Biobank, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Organoid Biobank that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Organoid Biobank total market, 2018-2029, (USD Million)
Global Organoid Biobank total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Organoid Biobank total market, key domestic companies and share, (USD Million)
Global Organoid Biobank revenue by player and market share 2018-2023, (USD Million)
Global Organoid Biobank total market by Type, CAGR, 2018-2029, (USD Million)
Global Organoid Biobank total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Organoid Biobank market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FRANKFURT CANCER INSTITUTE, Merck, Crown Bioscience, HUB Organoids, Cancer Research UK Convergence Science Centre, Thermo Fisher Scientific, Corning, STEMCELL Technologies and Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Organoid Biobank market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Organoid Biobank Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Organoid Biobank Market, Segmentation by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Global Organoid Biobank Market, Segmentation by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Companies Profiled:
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Key Questions Answered
1. How big is the global Organoid Biobank market?
2. What is the demand of the global Organoid Biobank market?
3. What is the year over year growth of the global Organoid Biobank market?
4. What is the total value of the global Organoid Biobank market?
5. Who are the major players in the global Organoid Biobank market?